(Q53723350)

18 May 2018

title

Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. (English)

1 reference

18 May 2018

author name string

Qi-Kai Sun

1

1 reference

18 May 2018

Jian-Yu Zhu

2

1 reference

18 May 2018

Wei Wang

3

1 reference

18 May 2018

Yang Lv

4

1 reference

18 May 2018

Hang-Cheng Zhou

5

1 reference

18 May 2018

Ji-Hai Yu

6

1 reference

18 May 2018

Ge-Liang Xu

7

1 reference

18 May 2018

Jin-Liang Ma

8

1 reference

18 May 2018

Wen Zhong

9

1 reference

18 May 2018

Wei-Dong Jia

10

1 reference

18 May 2018

publication date

3 December 2013

1 reference

18 May 2018

published in

Medical Oncology

1 reference

18 May 2018

volume

31

1 reference

18 May 2018

issue

1

1 reference

18 May 2018

page(s)

786

1 reference

18 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

RNA-binding properties and RNA chaperone activity of human peroxiredoxin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Peroxiredoxin I expression in human thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Hepatocellualar carcinoma serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0786-2

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

12 December 2020

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha

1 reference

12 December 2020

Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach

1 reference

12 December 2020

ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

1 reference

12 December 2020

10.1007/S12032-013-0786-2

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018